gptkbp:instanceOf
|
gptkb:Company
|
gptkbp:acquisition
|
gptkb:Claris_Lifesciences
Gambro
|
gptkbp:awards
|
Best Places to Work
Fortune 500 Company
DiversityInc Top 50
|
gptkbp:CEO
|
gptkb:José_E._Almeida
|
gptkbp:clinicalTrials
|
ongoing
|
gptkbp:employees
|
approximately 50,000
|
gptkbp:focus
|
pharmaceuticals
hospital products
renal care
surgical products
|
gptkbp:foundedIn
|
1931
|
gptkbp:founder
|
gptkb:D._J._Baxter
|
gptkbp:headquarters
|
gptkb:Deerfield,_Illinois
|
https://www.w3.org/2000/01/rdf-schema#label
|
Baxter Medical Products
|
gptkbp:industry
|
Healthcare
|
gptkbp:market
|
$40 billion (2021)
|
gptkbp:operatesIn
|
over 100 countries
|
gptkbp:partnerships
|
gptkb:Global_Fund
gptkb:World_Health_Organization
gptkb:American_Red_Cross
|
gptkbp:patentCitation
|
over 1,000
|
gptkbp:products
|
IV solutions
infusion systems
dialysis equipment
|
gptkbp:researchAndDevelopment
|
$1.5 billion (2020)
|
gptkbp:revenue
|
$11 billion (2020)
|
gptkbp:stockSymbol
|
BAX
|
gptkbp:subsidiary
|
gptkb:Baxter_Healthcare_Corporation
|
gptkbp:sustainabilityInitiatives
|
community engagement
employee well-being
environmental responsibility
|
gptkbp:trademark
|
Pharmaceuticals
Dialysis
Baxter
Renal
IV Solutions
Infusion_Systems
BioSurgery
|
gptkbp:website
|
www.baxter.com
|